DocDollars

Immunogen, Inc.

MA · United States · Reporting entity ID 100001306929

Total reported 2019–2025
$9.40M
#508 of 2,960 reporting companies — 0% of all reported industry payments
$1.33M in general payments across 3,351 records, plus $8.07M in research funding across 521 records.

How it breaks down

General payments $1,333,834
Research funding $8,068,152

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Immunogen, Inc. reported $9.40M to US doctors and teaching hospitals from 2019 to 2025, ranking #508 of 2,960 reporting companies. 86% of that was research funding and 14% general payments such as consulting, speaking, food and travel. 3,351 general payment records and 521 research records were filed.

Common questions about Immunogen, Inc.

How much has Immunogen, Inc. paid US doctors?

Immunogen, Inc. reported $9,401,986 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,333,834 in general payments, $8,068,152 in research funding.

How does Immunogen, Inc. rank among drug and device companies?

It ranks #508 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Immunogen, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.